#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Kardiovaskulární prevence v každodenní praxi

1. 10. 2026 Source: Athero Review | 2/2026

Consensus on the treatment of hyperuricemia in individuals at high cardiovascular risk –⁠ update 2025: brief summary

1. 10. 2026 Source: Athero Review | 2/2026

Semaglutide in the 2026 European Society of Cardiology guidelines

1. 10. 2026 Source: Athero Review | 2/2026

The level of control of cardiovascular risk factors in patients with type 2 diabetes and hypertension in the routine clinical practice of primary care physicians: results of the BEAT study

1. 10. 2026 Source: Athero Review | 2/2026

Anti-atherosclerotic potential of SGLT2 inhibitors: what do the recent data show?

1. 10. 2026 Source: Athero Review | 2/2026

The role of DLCN in the diagnosis of familial hypercholesterolemia: data from the MedPed Center in Bratislava

1. 10. 2026 Source: Athero Review | 2/2026

Bempedoic acid in older adults: new data

1. 10. 2026 Source: Athero Review | 2/2026

Lipoprotein(a) and ischemic stroke

1. 10. 2026 Source: Athero Review | 2/2026

Nanoplastics –⁠ is this really a new risk factor for cardiovascular disease?

1. 10. 2026 Source: Athero Review | 2/2026

Research on remarkable articles from international literature

1. 10. 2026 Source: Athero Review | 2/2026

Six-month doctoral fellowship at the Renal and Cardiovascular Research Unit, University of Salamanca, made possible by ČSAT

1. 10. 2026 Source: Athero Review | 2/2026

Šobra Day 2026: From the roots of lipidology to its future

1. 10. 2026 Source: Athero Review | 2/2026
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#